Preclinical evaluation of the efficacy of α-Difluoromethylornithine and Sulindac against SARS-CoV-2 infection
Natalia A. Ignatenko, Hien T. Trinh, April M Wagner, Eugene W. Gerner, Christian Bime, Chiu-Hsieh Hsu, David G. Besselsen
This study evaluates DFMO and Sulindac's antiviral efficacy against SARS-CoV-2 in cell lines and mice, showing age- and sex-dependent protective effects.
Viruses · Sep 26, 2025Peer-reviewedCell Biology